nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethionamide—Neurotoxicity—Gemcitabine—urinary bladder cancer	0.03	0.03	CcSEcCtD
Ethionamide—Neurotoxicity—Cisplatin—urinary bladder cancer	0.0279	0.0279	CcSEcCtD
Ethionamide—Neurotoxicity—Etoposide—urinary bladder cancer	0.0256	0.0256	CcSEcCtD
Ethionamide—Hypothyroidism—Thiotepa—urinary bladder cancer	0.0215	0.0215	CcSEcCtD
Ethionamide—Taste metallic—Methotrexate—urinary bladder cancer	0.0187	0.0187	CcSEcCtD
Ethionamide—Optic neuritis—Cisplatin—urinary bladder cancer	0.0176	0.0176	CcSEcCtD
Ethionamide—Optic neuritis—Etoposide—urinary bladder cancer	0.0161	0.0161	CcSEcCtD
Ethionamide—Neuritis—Gemcitabine—urinary bladder cancer	0.0156	0.0156	CcSEcCtD
Ethionamide—Drowsiness—Mitomycin—urinary bladder cancer	0.0154	0.0154	CcSEcCtD
Ethionamide—Neurotoxicity—Methotrexate—urinary bladder cancer	0.0153	0.0153	CcSEcCtD
Ethionamide—Stomatitis—Mitomycin—urinary bladder cancer	0.015	0.015	CcSEcCtD
Ethionamide—Neurotoxicity—Epirubicin—urinary bladder cancer	0.0143	0.0143	CcSEcCtD
Ethionamide—Neurotoxicity—Doxorubicin—urinary bladder cancer	0.0133	0.0133	CcSEcCtD
Ethionamide—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.0116	0.0116	CcSEcCtD
Ethionamide—Vision blurred—Mitomycin—urinary bladder cancer	0.0113	0.0113	CcSEcCtD
Ethionamide—Abdominal pain—Valrubicin—urinary bladder cancer	0.0112	0.0112	CcSEcCtD
Ethionamide—Diarrhoea—Valrubicin—urinary bladder cancer	0.00973	0.00973	CcSEcCtD
Ethionamide—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00959	0.00959	CcSEcCtD
Ethionamide—Photosensitivity—Fluorouracil—urinary bladder cancer	0.00944	0.00944	CcSEcCtD
Ethionamide—Dizziness—Valrubicin—urinary bladder cancer	0.0094	0.0094	CcSEcCtD
Ethionamide—Anorexia—Mitomycin—urinary bladder cancer	0.00934	0.00934	CcSEcCtD
Ethionamide—Vomiting—Valrubicin—urinary bladder cancer	0.00904	0.00904	CcSEcCtD
Ethionamide—Optic neuritis—Epirubicin—urinary bladder cancer	0.00904	0.00904	CcSEcCtD
Ethionamide—Rash—Valrubicin—urinary bladder cancer	0.00896	0.00896	CcSEcCtD
Ethionamide—Dermatitis—Valrubicin—urinary bladder cancer	0.00896	0.00896	CcSEcCtD
Ethionamide—Headache—Valrubicin—urinary bladder cancer	0.00891	0.00891	CcSEcCtD
Ethionamide—Somnolence—Mitomycin—urinary bladder cancer	0.00871	0.00871	CcSEcCtD
Ethionamide—Decreased appetite—Mitomycin—urinary bladder cancer	0.00851	0.00851	CcSEcCtD
Ethionamide—Nausea—Valrubicin—urinary bladder cancer	0.00845	0.00845	CcSEcCtD
Ethionamide—Optic neuritis—Doxorubicin—urinary bladder cancer	0.00836	0.00836	CcSEcCtD
Ethionamide—Jaundice—Thiotepa—urinary bladder cancer	0.00753	0.00753	CcSEcCtD
Ethionamide—Stomatitis—Thiotepa—urinary bladder cancer	0.00753	0.00753	CcSEcCtD
Ethionamide—Neuritis—Epirubicin—urinary bladder cancer	0.00745	0.00745	CcSEcCtD
Ethionamide—Orthostatic hypotension—Cisplatin—urinary bladder cancer	0.00718	0.00718	CcSEcCtD
Ethionamide—Neuritis—Doxorubicin—urinary bladder cancer	0.00689	0.00689	CcSEcCtD
Ethionamide—Diarrhoea—Mitomycin—urinary bladder cancer	0.0067	0.0067	CcSEcCtD
Ethionamide—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00654	0.00654	CcSEcCtD
Ethionamide—Dizziness—Mitomycin—urinary bladder cancer	0.00648	0.00648	CcSEcCtD
Ethionamide—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.00637	0.00637	CcSEcCtD
Ethionamide—Stomatitis—Gemcitabine—urinary bladder cancer	0.00633	0.00633	CcSEcCtD
Ethionamide—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.00626	0.00626	CcSEcCtD
Ethionamide—Vomiting—Mitomycin—urinary bladder cancer	0.00623	0.00623	CcSEcCtD
Ethionamide—Stomatitis—Fluorouracil—urinary bladder cancer	0.00623	0.00623	CcSEcCtD
Ethionamide—Rash—Mitomycin—urinary bladder cancer	0.00618	0.00618	CcSEcCtD
Ethionamide—Dermatitis—Mitomycin—urinary bladder cancer	0.00617	0.00617	CcSEcCtD
Ethionamide—Headache—Mitomycin—urinary bladder cancer	0.00614	0.00614	CcSEcCtD
Ethionamide—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.00594	0.00594	CcSEcCtD
Ethionamide—Stomatitis—Cisplatin—urinary bladder cancer	0.0059	0.0059	CcSEcCtD
Ethionamide—Nausea—Mitomycin—urinary bladder cancer	0.00582	0.00582	CcSEcCtD
Ethionamide—Vision blurred—Thiotepa—urinary bladder cancer	0.00569	0.00569	CcSEcCtD
Ethionamide—Agitation—Thiotepa—urinary bladder cancer	0.00555	0.00555	CcSEcCtD
Ethionamide—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.00544	0.00544	CcSEcCtD
Ethionamide—Jaundice—Etoposide—urinary bladder cancer	0.00541	0.00541	CcSEcCtD
Ethionamide—Stomatitis—Etoposide—urinary bladder cancer	0.00541	0.00541	CcSEcCtD
Ethionamide—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.0054	0.0054	CcSEcCtD
Ethionamide—Gynaecomastia—Methotrexate—urinary bladder cancer	0.00532	0.00532	CcSEcCtD
Ethionamide—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.005	0.005	CcSEcCtD
Ethionamide—Photosensitivity—Methotrexate—urinary bladder cancer	0.00491	0.00491	CcSEcCtD
Ethionamide—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00482	0.00482	CcSEcCtD
Ethionamide—Vision blurred—Fluorouracil—urinary bladder cancer	0.0047	0.0047	CcSEcCtD
Ethionamide—Anorexia—Thiotepa—urinary bladder cancer	0.0047	0.0047	CcSEcCtD
Ethionamide—Photosensitivity—Epirubicin—urinary bladder cancer	0.0046	0.0046	CcSEcCtD
Ethionamide—Vascular purpura—Epirubicin—urinary bladder cancer	0.00451	0.00451	CcSEcCtD
Ethionamide—Vision blurred—Cisplatin—urinary bladder cancer	0.00446	0.00446	CcSEcCtD
Ethionamide—Somnolence—Thiotepa—urinary bladder cancer	0.00438	0.00438	CcSEcCtD
Ethionamide—Dyspepsia—Thiotepa—urinary bladder cancer	0.00434	0.00434	CcSEcCtD
Ethionamide—Decreased appetite—Thiotepa—urinary bladder cancer	0.00428	0.00428	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00425	0.00425	CcSEcCtD
Ethionamide—Photosensitivity—Doxorubicin—urinary bladder cancer	0.00425	0.00425	CcSEcCtD
Ethionamide—Dysgeusia—Etoposide—urinary bladder cancer	0.00425	0.00425	CcSEcCtD
Ethionamide—Purpura—Epirubicin—urinary bladder cancer	0.00419	0.00419	CcSEcCtD
Ethionamide—Vascular purpura—Doxorubicin—urinary bladder cancer	0.00417	0.00417	CcSEcCtD
Ethionamide—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.00414	0.00414	CcSEcCtD
Ethionamide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00406	0.00406	CcSEcCtD
Ethionamide—Diplopia—Epirubicin—urinary bladder cancer	0.00404	0.00404	CcSEcCtD
Ethionamide—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00403	0.00403	CcSEcCtD
Ethionamide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00399	0.00399	CcSEcCtD
Ethionamide—Anorexia—Gemcitabine—urinary bladder cancer	0.00395	0.00395	CcSEcCtD
Ethionamide—Abdominal pain—Thiotepa—urinary bladder cancer	0.00389	0.00389	CcSEcCtD
Ethionamide—Anorexia—Fluorouracil—urinary bladder cancer	0.00388	0.00388	CcSEcCtD
Ethionamide—Purpura—Doxorubicin—urinary bladder cancer	0.00387	0.00387	CcSEcCtD
Ethionamide—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.00383	0.00383	CcSEcCtD
Ethionamide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00378	0.00378	CcSEcCtD
Ethionamide—Diplopia—Doxorubicin—urinary bladder cancer	0.00373	0.00373	CcSEcCtD
Ethionamide—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00369	0.00369	CcSEcCtD
Ethionamide—Somnolence—Gemcitabine—urinary bladder cancer	0.00368	0.00368	CcSEcCtD
Ethionamide—Anorexia—Cisplatin—urinary bladder cancer	0.00368	0.00368	CcSEcCtD
Ethionamide—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00363	0.00363	CcSEcCtD
Ethionamide—Somnolence—Fluorouracil—urinary bladder cancer	0.00362	0.00362	CcSEcCtD
Ethionamide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.0036	0.0036	CcSEcCtD
Ethionamide—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00359	0.00359	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00358	0.00358	CcSEcCtD
Ethionamide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00354	0.00354	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00352	0.00352	CcSEcCtD
Ethionamide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00346	0.00346	CcSEcCtD
Ethionamide—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00343	0.00343	CcSEcCtD
Ethionamide—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00341	0.00341	CcSEcCtD
Ethionamide—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.0034	0.0034	CcSEcCtD
Ethionamide—Anorexia—Etoposide—urinary bladder cancer	0.00337	0.00337	CcSEcCtD
Ethionamide—Diarrhoea—Thiotepa—urinary bladder cancer	0.00337	0.00337	CcSEcCtD
Ethionamide—Decreased appetite—Cisplatin—urinary bladder cancer	0.00336	0.00336	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00333	0.00333	CcSEcCtD
Ethionamide—Drowsiness—Methotrexate—urinary bladder cancer	0.00332	0.00332	CcSEcCtD
Ethionamide—Depression—Methotrexate—urinary bladder cancer	0.00331	0.00331	CcSEcCtD
Ethionamide—Dizziness—Thiotepa—urinary bladder cancer	0.00326	0.00326	CcSEcCtD
Ethionamide—Stomatitis—Methotrexate—urinary bladder cancer	0.00324	0.00324	CcSEcCtD
Ethionamide—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00318	0.00318	CcSEcCtD
Ethionamide—Weight decreased—Epirubicin—urinary bladder cancer	0.00316	0.00316	CcSEcCtD
Ethionamide—Somnolence—Etoposide—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Ethionamide—Vomiting—Thiotepa—urinary bladder cancer	0.00313	0.00313	CcSEcCtD
Ethionamide—Drowsiness—Epirubicin—urinary bladder cancer	0.00311	0.00311	CcSEcCtD
Ethionamide—Rash—Thiotepa—urinary bladder cancer	0.00311	0.00311	CcSEcCtD
Ethionamide—Dermatitis—Thiotepa—urinary bladder cancer	0.0031	0.0031	CcSEcCtD
Ethionamide—Headache—Thiotepa—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Ethionamide—Decreased appetite—Etoposide—urinary bladder cancer	0.00308	0.00308	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00305	0.00305	CcSEcCtD
Ethionamide—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00305	0.00305	CcSEcCtD
Ethionamide—Jaundice—Epirubicin—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Ethionamide—Stomatitis—Epirubicin—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Ethionamide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.003	0.003	CcSEcCtD
Ethionamide—Hepatitis—Methotrexate—urinary bladder cancer	0.00298	0.00298	CcSEcCtD
Ethionamide—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00295	0.00295	CcSEcCtD
Ethionamide—Nausea—Thiotepa—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Ethionamide—Weight decreased—Doxorubicin—urinary bladder cancer	0.00292	0.00292	CcSEcCtD
Ethionamide—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00289	0.00289	CcSEcCtD
Ethionamide—Drowsiness—Doxorubicin—urinary bladder cancer	0.00288	0.00288	CcSEcCtD
Ethionamide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00285	0.00285	CcSEcCtD
Ethionamide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Ethionamide—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Ethionamide—Stomatitis—Doxorubicin—urinary bladder cancer	0.0028	0.0028	CcSEcCtD
Ethionamide—Jaundice—Doxorubicin—urinary bladder cancer	0.0028	0.0028	CcSEcCtD
Ethionamide—Abdominal pain—Etoposide—urinary bladder cancer	0.0028	0.0028	CcSEcCtD
Ethionamide—Hepatitis—Epirubicin—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Ethionamide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Ethionamide—Dizziness—Fluorouracil—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Ethionamide—Diarrhoea—Cisplatin—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Ethionamide—Vomiting—Gemcitabine—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Ethionamide—Rash—Gemcitabine—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Ethionamide—Dermatitis—Gemcitabine—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Ethionamide—Hypersensitivity—Etoposide—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Ethionamide—Headache—Gemcitabine—urinary bladder cancer	0.0026	0.0026	CcSEcCtD
Ethionamide—Vomiting—Fluorouracil—urinary bladder cancer	0.00259	0.00259	CcSEcCtD
Ethionamide—Hepatitis—Doxorubicin—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Ethionamide—Rash—Fluorouracil—urinary bladder cancer	0.00257	0.00257	CcSEcCtD
Ethionamide—Dermatitis—Fluorouracil—urinary bladder cancer	0.00257	0.00257	CcSEcCtD
Ethionamide—Headache—Fluorouracil—urinary bladder cancer	0.00255	0.00255	CcSEcCtD
Ethionamide—Dysgeusia—Methotrexate—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Ethionamide—Nausea—Gemcitabine—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Ethionamide—Vomiting—Cisplatin—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Ethionamide—Vision blurred—Methotrexate—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Ethionamide—Rash—Cisplatin—urinary bladder cancer	0.00244	0.00244	CcSEcCtD
Ethionamide—Dermatitis—Cisplatin—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Ethionamide—Diarrhoea—Etoposide—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Ethionamide—Nausea—Fluorouracil—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Ethionamide—Dysgeusia—Epirubicin—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Ethionamide—Dizziness—Etoposide—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Ethionamide—Nausea—Cisplatin—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Ethionamide—Vision blurred—Epirubicin—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Ethionamide—Vomiting—Etoposide—urinary bladder cancer	0.00225	0.00225	CcSEcCtD
Ethionamide—Agitation—Epirubicin—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Ethionamide—Rash—Etoposide—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Ethionamide—Dermatitis—Etoposide—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Ethionamide—Headache—Etoposide—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Ethionamide—Dysgeusia—Doxorubicin—urinary bladder cancer	0.0022	0.0022	CcSEcCtD
Ethionamide—Vision blurred—Doxorubicin—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Ethionamide—Nausea—Etoposide—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Ethionamide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Ethionamide—Agitation—Doxorubicin—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Ethionamide—Anorexia—Methotrexate—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Ethionamide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Ethionamide—Anorexia—Epirubicin—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Ethionamide—Somnolence—Methotrexate—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Ethionamide—Dyspepsia—Methotrexate—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Ethionamide—Decreased appetite—Methotrexate—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Ethionamide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Ethionamide—Somnolence—Epirubicin—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Ethionamide—Anorexia—Doxorubicin—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Ethionamide—Dyspepsia—Epirubicin—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Ethionamide—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Ethionamide—Decreased appetite—Epirubicin—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Ethionamide—Abdominal pain—Methotrexate—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Ethionamide—Somnolence—Doxorubicin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Ethionamide—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Ethionamide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Ethionamide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Ethionamide—Abdominal pain—Epirubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Ethionamide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Ethionamide—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Ethionamide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Ethionamide—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Ethionamide—Diarrhoea—Methotrexate—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Ethionamide—Dizziness—Methotrexate—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Ethionamide—Diarrhoea—Epirubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Ethionamide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Ethionamide—Vomiting—Methotrexate—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Ethionamide—Rash—Methotrexate—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Ethionamide—Dermatitis—Methotrexate—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Ethionamide—Headache—Methotrexate—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Ethionamide—Dizziness—Epirubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Ethionamide—Vomiting—Epirubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Ethionamide—Nausea—Methotrexate—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Ethionamide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Ethionamide—Rash—Epirubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Ethionamide—Dermatitis—Epirubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Ethionamide—Headache—Epirubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Ethionamide—Dizziness—Doxorubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Ethionamide—Nausea—Epirubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Ethionamide—Vomiting—Doxorubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Ethionamide—Rash—Doxorubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Ethionamide—Dermatitis—Doxorubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Ethionamide—Headache—Doxorubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Ethionamide—Nausea—Doxorubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
